Fingerprint
Dive into the research topics of 'Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer
Tien Hoang, KyungMann Kim, Anthony Jaslowski, Paul Koch, Peter Beatty, James McGovern, Maria Quisumbing, Gary Shapiro, Robert Witte, Joan H. Schiller
Research output: Contribution to journal › Article › peer-review
56
Scopus
citations